11th LIPIDCLUB 2016 The MIGHTY MEDIC Gobal Scientific Society
[slideshow_deploy id=’1008′]
WAA/SFH Joint Congress, Paris, 27–29 April 2016
WAA/SFH Joint Congress, Paris, 27–29 April 2016
Archivio mensile:Aprile 2016
11th LIPIDCLUB 2016 The MIGHTY MEDIC Gobal Scientific Society
World Congress on Clinical Lipidology 10 – 12 February, 2017 Brisbane, Australia
World Congress on Clinical Lipidology 10 – 12 February, 2017 Brisbane, Australia
EFFICACY OF ALIROCUMAB IN 1,191 PATIENTS WITH A WIDE SPECTRUM OF MUTATIONS IN GENES CAUSATIVE FOR FAMILIAL HYPERCHOLESTEROLEMIA
Authors: John J.P. Kastelein, Gisle Langslet, Paul Hopkins, Joep Defesche, Werner Seiz, Marie Baccara-Dinet, Sara Hamon, Poulabi Banerjee, Claudia Stefanutti, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA, Sanofi, Montpellier, France Background: Next Generation Sequencing was performed to examine treatment response with alirocumab in patients carrying one or more causative mutation(s) in five familial …
Efficacy of Alirocumab in 1191 Patients with a Wide Spectrum of Mutations in Genes Causative for Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is characterized by high levels of low-density lipoprotein cholesterol (LDL-C) and increased risk of developing premature coronary heart disease. The prevalence of heterozygous and homozygous FH has been estimated to be 1:200 to 1:500 and 1:160,000 to 1:1,000,000, respectively. In plasma, LDL-C levels are regulated via apolipoprotein …
The third annual congress of the Association for Preventive Pediatrics Serbia with international participation
“PREVENTION IN PEDIATRICS – BASIS FOR HEALTHY LIFE AND LONGEVITY” 15 – 17 April 2016. Hotel Holiday Inn, Belgrade
Serbia Assoc of Peds
Serbia Assoc of Peds: Final Program [slideshow_deploy id=’1019′]